A carregar...
Treatment of chronic hepatitis B patients with tyrosine-methionine-aspartate-aspartate mutations
Lamivudine is an antiviral used for the treatment of chronic hepatitis B. Several studies have reported various mutations that are induced by lamivudine therapy. These mutations in the tyrosine-methionine-aspartate-aspartate (YMDD) motif are necessary and sufficient to confer high-level lamivudine r...
Na minha lista:
| Publicado no: | World J Gastroenterol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Baishideng Publishing Group Inc
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4722003/ https://ncbi.nlm.nih.gov/pubmed/26819537 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v22.i4.1727 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|